Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Intellipharmaceutics International Inc IPCIQ

Intellipharmaceutics International Inc is a Canada-based pharmaceutical company engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. Based on this... see more

GREY:IPCIQ - Post Discussion

Intellipharmaceutics International Inc > Pill deserved the no vote but it's an easy fix.
View:
Post by Fonziee on Jan 19, 2020 8:38pm

Pill deserved the no vote but it's an easy fix.

The pill its easier to crush and snort which is the main way of abuse. Also it has a more intense rapid onset when snorted so it is ideal for the ABUSER! That's why it failed. Ipci has nailed down the Iv side. Ipci needs to put that dye back in they took out listening to the fda and if possible make pill abit harder if not the dye takes care of the nasal route and it's a done deal. Why no one from ipci said anything about this at the meeting is beyond me. Getting it fixed quick which they already know how to do and resubmit for approval and lets get this show on the road
Comment by bigkagan on Jan 20, 2020 12:15am
you don't know nothing, IPCI has already done what FDA wanted them to do, it's impossible to improve the pill any further, FDA has to approve it as it is
Comment by Fonziee on Feb 10, 2020 9:18pm
i know more than you bigkagan, Sorry you lost all your stack and are trying to pump something when there is nothing. Hence your the only one on this board. They messed up making pill to easy to snort and the pill has a higher rapid onset. Will not get approved like this sorry. I too lost some money but that is why it's called gambling. Don't play with what you can't afford to lose
Comment by bigkagan on Feb 11, 2020 3:06pm
it's still better than the rest of the Oxy pills, at least they tried to do something. And how do you know it, have you tried to snort it? They haven't released the damn thing yet
Comment by bigkagan on Feb 14, 2020 4:03pm
is it a coincidence that IPCI is up 10% exactly a month since the unfortunate AdCom meeting? I don't think so. FDA could have already rejected it if it really wanted, the longer there is no decision the more likely a positive answer IMHO
Comment by Priotoma on Apr 17, 2020 1:35pm
It's been 3 months since AdCom meeting and really unknown the reason behind not publishing the final  result. Looks like FDA doesn't have answer to say NO to IPCI. on the other hand they are also considering the AdCom vote ratio. So, they are in a fix what they will do. It is very unfortunate if FDA considering AdCom vote. Okay, to me AdCom reason behind voting against IPCI is like< ...more  
Comment by Fonziee on Feb 17, 2020 5:59pm
if you watched the conference live on the internet and paid attention, it told you everything about the pill and why it is easier to snort and provides a more instant high effect. You should do your DD on what u invest in. Sell sell sell
Comment by Joeplow on Mar 01, 2020 5:26pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities